158 related articles for article (PubMed ID: 16596815)
1. Inhibition of lipoprotein lipid oxidation.
Cynshi O; Stocker R
Handb Exp Pharmacol; 2005; (170):563-90. PubMed ID: 16596815
[TBL] [Abstract][Full Text] [Related]
2. Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed.
Ahmad F; Leake DS
Chem Phys Lipids; 2018 Jul; 213():13-24. PubMed ID: 29518380
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and action of antiatherogenic antioxidants.
Cynshi O; Tamura K; Niki E
Methods Mol Biol; 2010; 610():91-107. PubMed ID: 20013174
[TBL] [Abstract][Full Text] [Related]
4. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation.
Frei B
Crit Rev Food Sci Nutr; 1995 Jan; 35(1-2):83-98. PubMed ID: 7748483
[TBL] [Abstract][Full Text] [Related]
6. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
[TBL] [Abstract][Full Text] [Related]
7. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug?
Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S
Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950
[TBL] [Abstract][Full Text] [Related]
8. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of low density lipoprotein oxidation in vitro by the 6- and 7-hydroxy-metabolites of doxazosin, an alpha 1-adrenergic antihypertensive agent.
Chait A; Gilmore M; Kawamura M
Am J Hypertens; 1994 Feb; 7(2):159-67. PubMed ID: 8179851
[TBL] [Abstract][Full Text] [Related]
10. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.
Iuliano L; Colavita AR; Camastra C; Bello V; Quintarelli C; Alessandroni M; Piovella F; Violi F
Br J Pharmacol; 1996 Dec; 119(7):1438-46. PubMed ID: 8968553
[TBL] [Abstract][Full Text] [Related]
11. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
Thomas SR; Stocker R
Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
[TBL] [Abstract][Full Text] [Related]
12. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
13. Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia.
Dujovne CA; Harris WS; Gerrond LL; Fan J; Muzio F
Am J Cardiol; 1994 Jul; 74(1):38-42. PubMed ID: 8017303
[TBL] [Abstract][Full Text] [Related]
14. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development.
Aviram M; Kaplan M; Rosenblat M; Fuhrman B
Handb Exp Pharmacol; 2005; (170):263-300. PubMed ID: 16596803
[TBL] [Abstract][Full Text] [Related]
15. Green tea catechins prevent low-density lipoprotein oxidation via their accumulation in low-density lipoprotein particles in humans.
Suzuki-Sugihara N; Kishimoto Y; Saita E; Taguchi C; Kobayashi M; Ichitani M; Ukawa Y; Sagesaka YM; Suzuki E; Kondo K
Nutr Res; 2016 Jan; 36(1):16-23. PubMed ID: 26773777
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies on the antioxidant activities of nine common food legumes against copper-induced human low-density lipoprotein oxidation in vitro.
Xu BJ; Yuan SH; Chang SK
J Food Sci; 2007 Sep; 72(7):S522-7. PubMed ID: 17995667
[TBL] [Abstract][Full Text] [Related]
17. Crocetin attenuates atherosclerosis in hyperlipidemic rabbits through inhibition of LDL oxidation.
Zheng S; Qian Z; Sheng L; Wen N
J Cardiovasc Pharmacol; 2006 Jan; 47(1):70-6. PubMed ID: 16424788
[TBL] [Abstract][Full Text] [Related]
18. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
19. Salvianolic acid B inhibits low-density lipoprotein oxidation and neointimal hyperplasia in endothelium-denuded hypercholesterolaemic rabbits.
Yang TL; Lin FY; Chen YH; Chiu JJ; Shiao MS; Tsai CS; Lin SJ; Chen YL
J Sci Food Agric; 2011 Jan; 91(1):134-41. PubMed ID: 20824680
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients.
Sundaram V; Hanna AN; Lubow GP; Koneru L; Falko JM; Sharma HM
Am J Med Sci; 1997 Nov; 314(5):303-10. PubMed ID: 9365332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
